Selective oxidation and externalization of membrane phosphatidylserine: Bcl-2-induced potentiation of the final common pathway for apoptosis

Brain Research

Volumn 831, Issue 1-2, 1999, Pages 125-130

  Schor, Nina Felice ^a,c,d   Tyurina, Yulia Y ^b,e   Fabisiak, James P ^a   Tyurin, Vladimir A ^b   Lazo, John S ^a,c   Kagan, Valerian E ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^e SECHENOV INSTITUTE OF EVOLUTIONARY PHYSIOLOGY AND BIOCHEMISTRY   (Russian Federation)

Author keywords

Apoptosis; Membrane peroxidation; Phosphatidylserine; Phospholipid

Indexed keywords

MEMBRANE PROTEIN; PHOSPHATIDYLSERINE; PROTEIN BCL 2; ZINOSTATIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; DOSE RESPONSE; DRUG POTENTIATION; GENETIC TRANSFECTION; LIPID PEROXIDATION; MEMBRANE BINDING; NEURAL CREST; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; GENES, BCL-2; LIPID PEROXIDATION; MEMBRANES; OXIDATION-REDUCTION; PC12 CELLS; PHOSPHATIDYLSERINES; RATS; TRANSFECTION; ZINOSTATIN;

EID: 0033549248     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01414-6     Document Type: Article

References (20)

1. H. Albrecht, J. Tschopp, C.V. Jongeneel, Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kappa B by TNF, FEBS Lett. 351 (1994) 45-48.
2. M. Cortazzo, N.F. Schor, Potentiation of enediyne-induced apoptosis and differentiation by Bcl-2, Cancer Res. 56 (1996) 1199-1203.
3. M. Dole, G. Nunez, A.K. Merchant, J. Maybaum, C.K. Rode, C.A. Bloch, V.P. Castle, Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma, Cancer Res. 54 (1994) 3253-3259.
4. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis, Cancer Res. 55 (1995) 2576-2582.
5. L.M. Ellerby, H.M. Ellerby, S.M. Park, A.L. Holleran, G. Fiskum, D.J. Kane, M.P. Testa, C. Kayalar, D.E. Bredesen, Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2, J. Neurochem. 67 (1996) 1259-1267.
6. J.P. Fabisiak, V.E. Kagan, V.B. Ritov, D.E. Johnson, J.S. Lazo, Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis, Am. J. Physiol. 272 (1997) C675-C684, Cell Physiol. 41.
7. H.A. Gelbard, R.M. Boustany, N.F. Schor, Apoptosis in development and disease of the nervous system: Part 2. Apoptosis in childhood neuologic disease, Pediatr. Neurol. 16 (1997) 93-97.
8. T.L. Hartsell, L.M. Hinman, P.R. Hamann, N.F. Schor, Determinants of the response of neuroblastoma cells to DNA damage: the roles of pretreatment cell morphology and chemical nature of the damage, J. Pharmacol. Exp. Ther. 277 (1996) 1158-1166.
9. R.M. Kluck, E. Bossy-Wetzel, D.R. Green, D.D. Newmeyer, The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis, Science 275 (1997) 1132-1136.
10. G. Koopman, C.P. Reutelingsperger, G.A. Kuijten, R.M. Keehnen, S.T. Pals, M.H. van Oers, Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis, Blood 84 (1995) 1415-1420.
11. C. Ravanat, G. Archipoff, A. Beretz, G. Freund, J.P. Cazenave, J.M. Freyssinet, Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells, Biochem. J. 282 (1992) 7-13, Pt. 1.
12. V.B. Ritov, S. Banni, J.C. Yalowich, B.W. Day, H.G. Claycamp, F.P. Corongiu, V.E. Kagan, Non-random peroxidation of different classes of membrane phospholipids in live cells detected by metabolically integrated cis-parinaric acid, Biochim. Biophys. Acta 1283 (1996) 127-140.
13. T. Rosse, R. Olivier, L. Monney, M. Rager, S. Conus, I. Fellay, B. Jansen, C. Borner, Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c, Nature 391 (1998) 496-499.
14. J.F. Tait, D. Gibson, Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content, Arch. Biochem. Biophys. 298 (1992) 187-191.
15. Y.Y. Tyurina, V.A. Tyurin, G. Carta, P.J. Quinn, N.F. Schor, V.E. Kagan, Direct evidence for antioxidant effect of Bcl-2 in PC12 rat pheochromocytoma cells, Arch. Biochem. Biophys. 344 (1997) 413-423.
16. B. Verhoven, R.A. Schlegel, P. Williamson, Rapid loss and restoration of lipid asymmetry by different pathways in resealed erythrocyte ghosts, Biochim. Biophys. Acta 1026 (1990) 153-160.
17. I. Vermes, C. Haanen, H. Steffens-Nakken, C. Reutelingsperger, Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V, J. Immunol. Methods 184 (1995) 39-51.
18. K.A. Wood, R.J. Youle, Apoptosis and free radicals, Ann. NY Acad. Sci. 738 (1994) 400-407.
19. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, X. Wang, Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked, Science 275 (1997) 1129-1132.
20. B. Zhivotovsky, S. Orrenius, O.T. Brustugun, S.O. Doskeland, Injected cytochrome c induces apoptosis, Nature 391 (1998) 449-450.